NOT-CA-02-015: CHANGE OF RECEIPT DATE FOR EARLY CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH PHASE I EMPHASIS

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®



CHANGE OF RECEIPT DATE FOR EARLY CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH 
PHASE I EMPHASIS

Release Date:  January 14, 2002

NOTICE:  NOT-CA-02-015

National Cancer Institute

The National Cancer Institute (NCI) wishes to give notice of a change of 
receipt date for applications submitted in response to RFA CA-02-011, EARLY 
CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH PHASE I EMPHASIS.  This RFA 
appeared in the November 19, 2001 issue of the NIH Guide for Grants and 
Contracts.  The previous receipt date of March 21, 2002 has been changed to 
March 28, 2002.

All other aspects of this RFA remain unchanged.  This RFA can be accessed at 
the following URL:  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-02-011.html.
                         
INQUIRIES

Inquiries regarding this notice may be directed to:

Dr. Louise B. Grochow
Chief, Investigational Drug Branch 
Cancer Therapy Evaluation Program 
Division of Cancer Treatment and Diagnosis
National Cancer Institute 
Executive Plaza North, Room 7131
6130 Executive Blvd MSC 7426
Bethesda, MD  20892-7432 
Telephone:  (301) 496-1196 
Fax:  (301) 402-0428
E-mail:  [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices